Jacobson Pharma Completes Issue of HK$500 Million of Convertible Notes to Dragons 615 Limited and HH InRe JP, Ltd.
- Written by Reporters
HONG KONG, CHINA - Media OutReach - 3 October 2017 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce the completion of issue of the Convertible Notes in...